Inaugural conference of the European Society for Spatial Biology (ESSB)
- 12 – 13 December 2024, Berlin, Germany
- Venue: Hotel & Conference Center Titanic Chaussee Berlin
Welcome
On December 12 and 13, 2024, the inaugural conference of the ESSB will take place here in Berlin. We expect an interdisciplinary audience from various fields of life science including but not limited to pathologists, neuroscientists, tumor immunologists and developmental biologists. All levels of expertise, for example doctoral researchers, postdocs, and principal investigators will attend.
When registering for the conference, you can also tick whether you would like to become a member of the new society, which is free of charge for 2024. An annual membership fee from 2025 onwards will be decided at the 1st members‘ assembly in Berlin.
Tickets for the conference
Registration is open. We have set up a platform where you can register. Please note that you should enter the billing address here – not your private address. Payment methods are bank transfer and Paypal.
The Early Bird rate can be booked until 31 July 2024. We look forward to welcoming you to Berlin for a great meeting.
Student fee
Early Bird-
until 31.7.2024
-
Regular fee: 180 Euro
Academic fee
Early Bird-
until 31.7.2024
-
Regular fee: 250 Euro
Industry particpant fee
Early Bird-
until 31.7.2024
-
Regular fee: 600 Euro
Abstract submission
Would you like to present your work in the exciting field of spatial biology? We cordially invite you to submit abstracts for the poster session ! Deadline is the 31st of July 2024.
This is your opportunity to present your research to an engaged audience, receive valuable feedback and exchange ideas with like-minded people. Show your passion for spatial biology and become part of a vibrant community of researchers shaping the future. We look forward to receiving your abstracts and to pushing the boundaries of knowledge together!
Meet our Speakers
Here we introduce you to our speakers one by one.
Raza Ali
Cancer Research UK, Cambridge University, Cambridge, UK
Harsharan Bhatia
iTERM, Helmholtz Munich, Germany
Bernd Bodenmiller
Inst. f. Molecular Health Sciences, Zurich, Switzerland
Camila Engblom
Karolinska Institutet, Stockholm, Sweden
Leeat Keren
Weizmann Institute of Science, Rehovot, Israel
Joakim Lundeberg
SciLifeLab/KTH, Stockholm, Sweden
Peter Sorger
Harvard Medical School, Boston, USA
Nicole Strittmatter
TUM, Munic, Germany
Sanja Vickovic
Herbert and Florence Irving Institute for Cancer Dynamics, New York, USA/Sweden
Carolina Wählby
Uppsala University, Sweden